Health Care Treatment Decisions
Clinicians, patients, and health-policy makers often need to decide which treatment is “best” based on all relevant evidence, but randomized controlled trials (RCTs) that simultaneously compare all interventions of interest are rarely available. Network meta-analysis (NMA) is an approach which may be used to assess relative treatment differences, by combining data from more than one RCT.
Leverage Existing RCT Data
This method to leverage existing published data has widely increased in use, making it more and more critical that you understand the underlying assumptions when performing and interpreting this statistical analysis.
Join us for this webinar where you’ll learn:
- Terms such as direct and indirect comparisons, mixed-treatment comparisons, and network meta-analyses and why they are used.
- The difference between fixed and random effects and Frequentist and Bayesian methods.
- Concepts, assumptions, and limitations of NMAs, such as heterogeneity, inconsistency, and bias.
Want even more in-depth information? Register for our January 31 webinar on Advanced Network Meta-analysis: Recent Developments in Bayesian NMA